NCT07427316Not yet recruiting
Role of Arterial Spin Labelling Magnetic Resonance Prefusion in Grading of Pediatric Brain Tumors
Role of Arterial Spin Labelling Magnetic Resonance Perfusion in The Grading of Pediatric Brain Tumors
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
To evaluate the diagnostic performance of arterial spin labelling (ASL) magnetic resonance perfusion in preoperative grading of pediatric brain tumors.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 17 Feb 2026
- Start date
- Mar 2026
- Primary completion date
- Mar 2028
- Lead sponsor
- Assiut University
- Diseases
- Childhood cancers
- NCT number
- NCT07427316
What you commit to
- Study type: Observational
- Planned participants: 20
- From Mar 2026 to the primary completion date, Mar 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received prior surgery, chemotherapy or radiotherapy for brain tumors.
Other
- Patients with contraindications to magnetic resonance imaging (MRI) examination.
Who the study is looking for
- Pediatric patients aged 18 years or younger.
- Patients with radiological diagnosis of intracranial brain tumors.
Age in the registry: 0 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.